Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by firesIayer96on Nov 30, 2012 5:27pm
414 Views
Post# 20669068

MD&A Q ended Sept. 30, 2012

MD&A Q ended Sept. 30, 2012

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=95693

Of note:

*At September 30, 2012, the Company held cash and short-term deposits of $2,748,883.

*Total expenses for the quarter ended September 30, 2012 was $707,926 as compared to $1,002,501 befor the same period in 2011, representing a decrease of $1,002,501 (typo?, should read $294,575?). The decrease in expenses from 2011 to 2012 is mainly attributed to Stock Based Compensation costs which decreased by $462,612.

*Cash used in operations was $2,042,808 for the nine months ended September 30 2012, as compared to $1,444,107 for the same period in 2011. The increase in cash usage in 2012 as compared to 2012 is primarily the result of the Company’s increased operations and purchase of parts relating to manufacturing in 2012.

*Net cash provided by financing activities was $760,000 for the nine months ended September 30, 2012, compared to cash provided of $8,191,800 for the same period in 2011. The cash from financing activities in 2012 are attributable to warrant exercises. During the same period in 2011 the Company completed private placements totaling $6,000,000 with the rest of the cash from financing activities during that period attributable to stock option and warrant exercises. Management believes the Company’s current cash position is enough to support operations for at least the next 6 months.

Bullboard Posts